Anti-TNF α treatments
| Name | Description |
| D2E7 | Fully human anti-TNF α mAb |
| CDP571 | Humanised anti-TNF α mAb (murine CDR) |
| Etanercept | Fusion protein consisting of two recombinant p75 TNF α receptors and the Fc portion of human IgG1 |
| Infliximab (cA2) | Chimeric murine/human anti-TNF-α mAb |
TNF=tumour necrosis factor; mAb=monoclonal antibody; IgG=immunoglobulin G; CDR=complementarity determining region.